Cargando…

DRUG THERAPY IN KNEE OSTEOARTHROSIS

Clinical treatment for osteoarthritis (OA) is very important and is based on patient’s self care and guided by the physician. Drug therapy is additional to losing weight, improving muscular strength, proprioception, flexibility and range of motion. Between the available drugs for osteoarthritis’ tre...

Descripción completa

Detalles Bibliográficos
Autores principales: de Rezende, Márcia Uchôa, Gobbi, Riccardo Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783603/
https://www.ncbi.nlm.nih.gov/pubmed/26998447
http://dx.doi.org/10.1016/S2255-4971(15)30043-4
_version_ 1782420140204228608
author de Rezende, Márcia Uchôa
Gobbi, Riccardo Gomes
author_facet de Rezende, Márcia Uchôa
Gobbi, Riccardo Gomes
author_sort de Rezende, Márcia Uchôa
collection PubMed
description Clinical treatment for osteoarthritis (OA) is very important and is based on patient’s self care and guided by the physician. Drug therapy is additional to losing weight, improving muscular strength, proprioception, flexibility and range of motion. Between the available drugs for osteoarthritis’ treatment, some are basically analgesics and do not interfere on disease’s progression; some are anti-inflammatory with good analgesic power but with side effects that compromise their prolonged usage; and the structure modifying drugs that slow down the progression of OA. The medications are presented in topic, oral, intra-muscular, intra-venous and intra-articular forms. The hyaluronic acid has various presentations with good analgesic effect and some evidence of structure modifying property. There is IA evidence level for the use of diacerhein and of glucosamine to slow down the disease. Still, more technology for diagnosis and therapy control of OA is necessary to define the efficacy of other drugs.
format Online
Article
Text
id pubmed-4783603
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-47836032016-03-18 DRUG THERAPY IN KNEE OSTEOARTHROSIS de Rezende, Márcia Uchôa Gobbi, Riccardo Gomes Rev Bras Ortop Updating Article Clinical treatment for osteoarthritis (OA) is very important and is based on patient’s self care and guided by the physician. Drug therapy is additional to losing weight, improving muscular strength, proprioception, flexibility and range of motion. Between the available drugs for osteoarthritis’ treatment, some are basically analgesics and do not interfere on disease’s progression; some are anti-inflammatory with good analgesic power but with side effects that compromise their prolonged usage; and the structure modifying drugs that slow down the progression of OA. The medications are presented in topic, oral, intra-muscular, intra-venous and intra-articular forms. The hyaluronic acid has various presentations with good analgesic effect and some evidence of structure modifying property. There is IA evidence level for the use of diacerhein and of glucosamine to slow down the disease. Still, more technology for diagnosis and therapy control of OA is necessary to define the efficacy of other drugs. Elsevier 2015-12-06 /pmc/articles/PMC4783603/ /pubmed/26998447 http://dx.doi.org/10.1016/S2255-4971(15)30043-4 Text en © 2009 Sociedade Brasileira de Ortopedia e Traumatologia http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Updating Article
de Rezende, Márcia Uchôa
Gobbi, Riccardo Gomes
DRUG THERAPY IN KNEE OSTEOARTHROSIS
title DRUG THERAPY IN KNEE OSTEOARTHROSIS
title_full DRUG THERAPY IN KNEE OSTEOARTHROSIS
title_fullStr DRUG THERAPY IN KNEE OSTEOARTHROSIS
title_full_unstemmed DRUG THERAPY IN KNEE OSTEOARTHROSIS
title_short DRUG THERAPY IN KNEE OSTEOARTHROSIS
title_sort drug therapy in knee osteoarthrosis
topic Updating Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783603/
https://www.ncbi.nlm.nih.gov/pubmed/26998447
http://dx.doi.org/10.1016/S2255-4971(15)30043-4
work_keys_str_mv AT derezendemarciauchoa drugtherapyinkneeosteoarthrosis
AT gobbiriccardogomes drugtherapyinkneeosteoarthrosis